Core Focus
This biotech start-up will focus on the development and marketing of medical biotechnology products related to the IP that has and is being created by Prof Stefan Barth, SARChI Chair in Cancer Biotechnology. The company will access patents from his former institution (Fraunhofer), as well as other third-party IP in order to develop recombinant immunodiagnostics and targeted therapeutics.